MiMedx Group Inc (MDXG)

MiMedx Group Inc (MDXG) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $670M; returns 1 day -0.5%, 1 week -11.7%, 1 year -41.1%.

MiMedx Group Inc. is a medical technology company focused on developing, manufacturing, and marketing regenerative biomaterial products and bioimplants derived from human placental tissues. The company utilizes its proprietary PURION® processing technology to create allografts that retain inherent biological properties for healing applications.

Groups MDXG belongs to

MDXG financial model: income statement, cash flow and balance sheet